Blood pressure augmentation in acute ischemic stroke

Journal of the Neurological Sciences

Volumn 261, Issue 1-2, 2007, Pages 63-73

  Wityk, Robert J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute ischemic stroke; Blood pressure; Induced hypertension; Ischemic penumbra; Magnetic resonance imaging

Indexed keywords

DOPAMINE; FLUDROCORTISONE; HEPARIN; HYPERTENSIVE FACTOR; MIDODRINE; NORADRENALIN; PHENYLEPHRINE;

ACUTE DISEASE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN EDEMA; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE CONTROL; DRUG MECHANISM; DRUG WITHDRAWAL; HEART DISEASE; HUMAN; HYPERTENSION; HYPOTENSION; INTESTINE ISCHEMIA; MEAN ARTERIAL PRESSURE; NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; PHENYLEPHRINE;

EID: 34548178676     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.04.033     Document Type: Article

References (79)

1. Goldstein L.B., Adams R., Becker K., Furberg C.D., Gorelick P.B., Hademenos G., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 32 (2001) 280-299
2. Wolf P.A., Clagett G.P., Easton J.D., Goldstein L.B., Gorelick P.B., Kelly-Hayes M., et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30 (1999) 1991-1994
3. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
4. Bath P., Chalmers J., Powers W., Beilin L., Davis S., Lenfant C., et al. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 21 (2003) 665-672
5. Adams Jr. H.P., Adams R.J., Brott T., Del Zoppo G.J., Furlan A., Goldstein L.B., et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 (2003) 1056-1083
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
7. Baron J.C. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 11 (2001) 2-8
8. Astrup J., Siesjo B.K., and Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12 (1981) 723-725
9. Jones T.H., Morawetz R.B., Crowell R.M., Marcoux F.W., FitzGibbon S.J., DeGirolami U., et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54 (1981) 773-782
10. Fisher M., and Garcia J.H. Evolving stroke and the ischemic penumbra. Neurology 47 (1996) 884-888
11. Marchal G., Beaudouin V., Rioux P., de la Sayette V., Le Doze F., Viader F., et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 27 (1996) 599-606
12. Hakim A.M. Ischemic penumbra: the therapeutic window. Neurology 51 (1998) S44-S46
13. Fisher M., and Albers G.W. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology 52 (1999) 1750-1756
14. Wallace J.D., and Levy L.L. Blood pressure after stroke. JAMA 246 (1981) 177-2180
15. Broderick J., Brott T., Barsan W., Haley E.C., Levy D., Marler J., et al. Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med 22 (1993) 1438-1443
16. Carlberg B., Asplund K., and Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 24 (1993) 1372-1375
17. Demchuk A.M., Tanne D., Hill M.D., Kasner S.E., Hanson S., Grond M., et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 57 (2001) 474-480
18. Jorgensen H.S., Nakayama H., Raaschou H.O., and Olsen T.S. Effect of blood pressure and diabetes on stroke in progression. Lancet 344 (1994) 156-159
19. Aslanyan S., Fazekas F., Weir C.J., Horner S., and Lees K.R. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome. a tertiary analysis of the GAIN International Trial. Stroke 18 (2003) 18
20. Oliveira-Filho J., Silva S.C., Trabuco C.C., Pedreira B.B., Sousa E.U., and Bacellar A. Detrimental effect of blood pressure reduction in the first 24 h of acute stroke onset. Neurology 61 (2003) 1047-1051
21. Willmot M., Leonardi-Bee J., and Bath P.M.W. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 43 (2004) 18-24
22. Vemmos K.N., Tsivgoulis G., Spengos K., Manios E., Daffertshofer M., Kotsis V., et al. Pulse pressure in acute stroke is an independent predictor of long-term mortality. Cerebrovasc Dis 18 (2004) 30-36
23. Mattle H.P., Kappeler L., Arnold M., Fischer U., Nedeltchev K., Remonda L., et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 36 (2005) 264-268
24. Christensen H., Meden P., Overgaard K., and Boysen G. The course of blood pressure in acute stroke is related to the severity of the neurological deficits. Acta Neurol Scand 106 (2002) 142-147
25. Leonardi-Bee J., Bath P.M., Phillips S.J., and Sandercock P.A. Blood pressure and clinical outcomes in the international stroke trial. Stroke 33 (2002) 1315-1320
26. Vemmos K.N., Tsivgoulis G., Spengos K., Zakopoulos N., Synetos A., Manios E., et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 255 (2004) 257-265
27. Schrader J., Luders S., Kulschewski A., Berger J., Zidek W., Treib J., et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34 (2003) 1699-1703
28. Bath P.M., Pathansali R., Iddenden R., and Bath F.J. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 11 (2001) 265-272
29. Ahmed N., Nasman P., and Wahlgren N.G. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 31 (2000) 1250-1255
30. Lisk D.R., Grotta J.C., Lamki L.M., Tran H.D., Taylor J.W., Molony D.A., et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 50 (1993) 855-862
31. Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke. Art. No.: CD000039, doi:10.1002/14651858.CD000039. Date of last substantive update: March 04. 2001.
32. Graham D.I. Ischaemic brain damage of cerebral perfusion failure after treatment of severe hypertension. Br Med J 4 (1975) 739
33. Fischberg G.M., Lozano E., Rajamani K., Ameriso S., and Fisher M.J. Stroke precipitated by moderate blood pressure reduction. J Emerg Med 19 (2000) 339-346
34. Denny-Brown D. The Shattuck lecture. N Engl J Med 246 (1952) 839-846
35. Waltz A.G. Effect of blood pressure on blood flow in ischemic and nonischemic cerebral cortex. Neurology 18 (1968) 613-621
36. Symon L., Branston N.M., and Strong A.J. Autoregulation in acute focal ischemia. An experimental study. Stroke 7 (1976) 547-554
37. Hayashi S., Nehls D.G., Kieck C.F., Vielma J., DeGirolami U., and Crowell R.M. Beneficial effects of induced hypertension on experimental stroke in awake monkeys. J Neurosurg 60 (1984) 151-157
38. + at critical levels of brain ischemia. Stroke 8 (1977) 51-57
39. Olsen T.S., Larsen B., Herning M., Skriver E.B., and Lassen N.A. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke 14 (1983) 332-341
40. Agnoli A., Fieschi C., Bozzao L., Battistini N., and Prencipe M. Autoregulation of cerebral blood flow. Studies during drug-induced hypertension in normal subjects and in patients with cerebral vascular diseases. Circulation 28 (1968) 800-812
41. Denny-Brown D. The treatment of recurrent cerebrovascular symptoms and the question of "vasospasm". Med Clin North Am 35 (1951) 1457-1474
42. Denny-Brown D., and Meyer J.S. The cerebral collateral circulation. 2. Production of cerebral infarction by ischemic anoxia and its reversibility in early stages. Neurology 7 (1957) 567-579
43. Brawley B.W., Strandness D.E., and Kelly W.A. The physiologic response to therapy in experimental cerebral ischemia. Arch Neurol 17 (1967) 180-187
44. Hope D.T., Branston N.M., and Symon L. Restoration of neurologic function with induced hypertension in acute experimental cerebral ischemia. Acta Neurol Scand 64 (1977) 506-507
45. Drummond J.C., Oh Y., Cole D.J., and Shapiro H. Phenylephrine induced hypertension reduces ischemia following middle cerebral artery occlusion in rats. Stroke 20 (1989) 1538-1544
46. Chileuitt L., Leber K., McCalden T., and Weinstein P.R. Induced hypertension during ischemia reduces infarct area after temporary middle cerebral artery occlusion in rats. Surg Neurol 46 (1996) 229
47. Smrcka M., Ogilvy C.S., Crow R.J., Maynard K.I., Kawamata T., and Ames A.I. Induced hypertension improves regional blood flow and protects against infarction during focal ischemia: time course of changes in blood flow measured by laser Doppler imaging. Neurosurgery 42 (1998) 617-625
48. Hosomi N., Mizushige K., Kitadai M., Ohyama H., Ichihara S.-I., Takahashi T., et al. Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia. Brain Res 835 (1999) 188
49. Michenfelder J.D., and Milde J.H. Failure of prolonged hypocapnia, hypothermia or hypertension to favorably alter acute stroke in primates. Stroke 8 (1977) 87-91
50. Cole D.J., Matsumura J.S., Drummond J.C., and Schell R.M. Focal cerebral ischemia in rats: effects of induced hypertension, during reperfusion, on CBF. J Cereb Blood Flow Metab 12 (1992) 64-69
51. Shanbrom E., and Levy L. The role of systemic blood pressure in cerebral circulation in carotid and basilar artery thromboses. Am J Med 23 (1957) 197-204
52. Farhat S.M., and Schneider R.C. Observations on the effect of systemic blood pressure on intracranial circulation in patients with cerebrovascular insufficiency. J Neurosurg 27 (1967) 441-445
53. Wise G.R. Vasopressor-drug therapy for complications of cerebral angiography. N Engl J Med 282 (1970) 610-612
54. Wise G., Sutter R., and Burkholder J. The treatment of brain ischemia with vasopressor drugs. Stroke 3 (1972) 135-140
55. Ackerman R.H., Lev M.H., Mackay B.C., Katz P.M., Babikian V.L., Alpert N.M., et al. PET studies in acute stroke: findings and relevance to therapy. J Cereb Blood Flow Metab 9 (1989) [XXI-5]
56. Olsen T.S. Should induced hypertension or hypotension ever be used in the treatment of stroke?. Acta Med Scand 678 (1983) 113-120
57. Kassell N.F., Peerless S.J., Durward Q.J., Beck D.W., Drake C.G., and Adams H.P. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11 (1982) 337-343
58. Mayberg M.R., Batjer H.H., Dacey R., Diringer M., Haley E.C., Heros R.C., et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25 (1994) 2315-2328
59. Miller J.A., Dacey R.G., and Diringer M.N. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 26 (1995) 2260-2266
60. Bevan J.A., Duckworth J., Laher I., Oriowo M.A., McPherson G.A., and Bevan R.D. Sympathetic control of cerebral arteries: specialization in receptor type, reserve, affinity, and distribution. FASEB J 1 (1987) 193-198
61. Schwarz S., Georgiadis D., Aschoff A., and Schwab S. Effects of induced hypertension on intracranial pressure and flow velocities of the middle cerebral arteries in patients with large hemispheric stroke. Stroke 33 (2002) 998-1004
62. Rordorf G., Cramer S.C., Efird J.T., Schwamm L.H., Buonanno F., and Koroshetz W.J. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 28 (1997) 2133-2138
63. Rordorf G., Koroshetz W.J., Ezzeddine M.A., Segal A.Z., and Buonanno F.S. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 56 (2001) 1210-1213
64. Adams H.J., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Stroke 24 (1993) 35-41
65. Hillis A.E., Barker P.B., Beauchamp N.J., Gordon B., and Wityk R.J. MR perfusion imaging reveals regions of hypoperfusion associated with aphasia and neglect. Neurology 55 (2000) 782-788
66. Hillis A.E., Wityk R.J., Tuffiash E., Beauchamp N.J., Jacobs M.A., Barker P.B., et al. Hypoperfusion of Wernicke's area predicts severity of semantic deficit in acute stroke. Ann Neurol 50 (2001) 561-566
67. Hillis A.E., Barker P.B., Beauchamp N.J., Winters B.D., Mirski M., and Wityk R.J. Restoring blood pressure reperfused Wernicke's area and improved language. Neurology 56 (2001) 670-672
68. Hillis A.E., Kane A., Tuffiash E., Ulatowski J.A., Barker P.B., Beauchamp N.J., et al. Reperfusion of specific brain regions by raising blood pressure restores selective language functions in subacute stroke. Brain Lang 79 (2001) 495-510
69. Hillis A.E., Ulatowski J.A., Barker P.B., Torbey M., Ziai W., Beauchamp N.J., et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 16 (2003) 236-246
70. Hillis A.E., Wityk R.J., Beauchamp N.J., Ulatowski J.A., Jacobs M.A., and Barker P.B. Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke. Neuroradiology 46 (2004) 31-39
71. Marzan A.S., Hungerbuhler H.J., Studer A., Baumgartner R.W., and Georgiadis D. Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke. Neurology 62 (2004) 1193-1195
72. Koenig M.A., Geocadin R.G., de Grouchy M., Glasgow J., Vimal S., and Restrepo L. Safety of induced hypertension therapy in patients with acute ischemic stroke. Neurocritical Care 4 (2006) 3-7
73. Saxena R., et al., on behalf of the DCLHb in Acute Stroke Study Investigators. Induced elevation of blood pressure in the acute phase of ischemic stroke in humans. Stroke 31 (2000) 546-548
74. Campbell M.S., et al., On behalf of the NeuroFlo Investigators. Perfusion augmentation in stroke using controlled aortic obstruction: pilot study results. Stroke 35 (2004) 291
75. Duke B.J., Breeze R.E., Rubenstein D., Tranmer B.I., and Kindt G.W. Induced hypervolemia and inotropic support for acute cerebral arterial insufficiency: an underused therapy. Surg Neurol 49 (1998) 51
76. Caplan L.R. Worsening in ischemic stroke patients: is it time for a new strategy?. Stroke 33 (2002) 1443-1445
77. Johnston S.C., and Easton J.D. Are patients with acutely recovered cerebral ischemia more unstable?. Stroke 34 (2003) 2446-2450
78. The CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke). Pilot trial: rationale and design. J Hypertens 23 (2005) 649-655
79. Olsen T.S., and Lassen N.A. A dynamic concept of middle cerebral artery occlusion and cerebral infarction in the acute state based on interpreting severe hyperemia as a sign of embolic migration. Stroke 15 (1984) 458-468